The Massachusetts Biotechnology Council (MassBio) announced the release of its recent digital health report, Making Massachusetts a Leading Global Destination for Digital Health. The report, which was done by Deloitte, looks at the current state of the digital health industry in Massachusetts, challenges facing its growth, and opportunities the state has to lead.
The study also identified at least three key opportunities where Massachusetts stakeholders could invest time and resources to drive growth and differentiation of its digital health ecosystem These include, but are not limited to: fostering better access to data and patients; developing a workforce that is able to tackle complex healthcare challenges through digital technology; and better coordinating the digital health entrepreneur and investor ecosystems. In addition to advocating for what the state can do, MassBio plans to launch new initiatives to support digital health entrepreneurs.
To read or download the full report, visit here.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.